Grade-dependent Response to Finasteride in Early Prostate Cancer

EBioMedicine. 2016 May:7:13-4. doi: 10.1016/j.ebiom.2016.04.022. Epub 2016 Apr 19.

¹ Veterans Affairs Medical Center, 1201 N.W. 16th Street, Miami, FL 33125, USA; Department of Urology, Herbert Wertheim College of Medicine, Florida International University, 11200 SW 8th St, Miami, FL 33199, USA. Electronic address: ferencrick@gmail.com.
² Divisions of Hematology/Oncology and Endocrinology, Department of Medicine, University of Miami, Miller School of Medicine, 1800 N.W. 10th Ave, Miami, FL 33126, USA; Department of Pathology, University of Miami, Miller School of Medicine, 1800 N.W. 10th Ave, Miami, FL 33125, USA; Sylvester Comprehensive Cancer Center, University of Miami, Miller School of Medicine, 1800 N.W. 10th Ave, Miami, FL 33125, USA.

No abstract available

Keywords: 5-alpha reductase inhibitor; Androgen-deprivation therapy; Chemoprevention; Early prostate cancer; Finasteride; Gleason grade.

Publication types